⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TGTX News
TG Therapeutics, Inc.
TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update
globenewswire.com
TGTX
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
Mana.bio Announces the Appointment of Laura Sepp-Lorenzino to its Scientific Advisory Board
prnewswire.com
NTLA
VRTX
ALNY
MRK
TGTX
LXEO
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm
prnewswire.com
TGTX
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm
globenewswire.com
TGTX
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
globenewswire.com
TGTX
The Quest to Repair What Multiple Sclerosis Takes Away
globenewswire.com
QNTM
NVS
MRK
TGTX
BMY
Form 8-K
sec.gov
TGTX
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
globenewswire.com
TGTX
Form 8-K
sec.gov
TGTX